Skip to main content
Premium Trial:

Request an Annual Quote

Ayoxxa Raises $3.4M to Develop Protein Bead Array Platform

NEW YORK (GenomeWeb News) – Ayoxxa Biosystems announced today that it has netted €2.6 million ($3.4 million) in a Series A financing round.

The Cologne, Germany-based firm said it will use the proceeds to further develop and scale-up production of in situ encoded bead-based arrays that allow the simultaneous measurement of multiple proteins from small amounts of sample material.

CEO Andreas Schmidt said in a statement that the funding provides Ayoxxa with the resources to "significantly accelerate the scale-up of production" of its arrays ahead of commercialization.

Ayoxxa was founded as a spin-off of the National University of Singapore in 2010 and established its headquarters in Cologne earlier this year. The firm maintains an office in Singapore.

Its Series A investors included Wellington Partners Venture Capital, NRW.BANK, HTGF - High-Tech-Gründerfonds, as well as private investors Rainer Christine and Gregor Siebenkotten, both formerly executive board members and co-founders of Amaxa Biosystems.

Following the fundraising, Ayoxxa's board of directors consists of Chairman Rainer Christine; board members Regina Hodits and Matthias Dill from Wellington Partners, and Aristotelis Nastos from NRW.BANK; and board observers Lukas Günther from Wellington Partners and Florian Stinauer from NRW.BANK.

Hodits said in a statement that Ayoxxa's arrays have the potential to become the "new standard" for the analysis of multiple protein-protein interactions in limited sample volumes. She said that Ayoxxa will address a research market worth "hundreds of millions of dollars" and over the longer term will "reach into pharmaceutical screening and ultimately diagnostics."

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.